Introduction
Me dul l ary Th yroid Carcinom a (MTC) is anuncom m on but ch al l e nging m al ignant tum or th at aris e s from th e paraf ol l icul ar cal cit onin s e cre ting ce l l s of th e th yroid. 1,2 H e nce e l e vate d s e rum cal citonin l e ve l is a re l iabl e m ark e r for diffe re ntiate dre curre nt M TC. 3 M TC accounts f or 3% -10% of al l th yroid cance rs and 13.4% of al l th yroid-re l ate d de ath s . 4 According to th e oncol ogy re gis try re cord of th e Ins titute of Radioth e rapy and Nucl e ar M e dicine (IRNUM ), th e re are 59 cas e s of M TC in th e l as t 10 ye ars w h ich com pris e s about 0.09 % of al l m al ignant cas e s re gis te re d in th e h os pital .
In tim e diagnos is , s taging and as s e s s m e nt of re curre nce inm e dul l ary th yroid carcinom a (M TC) is of utm os t im portance f or th e prope r m anage m e nt of th e dis e as e . 5 Th is tum or is re s is tant to e xte rnal be am radioth e rapy (EBRT) and s h ow poor re s pons e to PJR October -December 2017; 27(4) : [408] [409] [410] [411] [412] [413] Te ch ne ctium -9 9 m Pe ntaval e nt Dim e captos uccinic acid ( 9 9 m Tc(V)-DM SA) s cintigraph y w as pe rform e d in a patie nt w ith h is topath ol ogical l y prove n m e dul l ary th yroid carcinom a h aving h igh l e ve l of cal citonin us ing a l ocal l y form ul ate d k it. M ark e d uptak e of th e radiotrace r w as obs e rve d by th e l ocal l y m e tas tatic foci. Th e s am e patie nt w as th e n s ubje cte d to s om atos tatin re ce ptor s cintigraph y (O ctre oScan) and th e re s ul ts w e re found com parabl e . Both th e s canning w as com pl e te d w ith in 24 h rs w ith good q ual ity im age s . In h ous e pre paration from re nal DM SA k it, be tte r re s ol ution, good s tabil ity and e as y proce dure w ith m inim um cos t m ak e 9 9 m Tc(V)-DM SA, a good im aging age nt for vis ual iz ation of m e dul l ary th yroid carcinom a in ce ntre 's w h e re 9 9 m Tc-EDDA/H YNIC-Tyr 3 -O ctre otide is not avail abl e . K e y w ords : O ctre otide , M TC, Cal citonin, 9 9 m Tc (V)-DM SA, Radioch e m ical purity ch e m oth e rapy. H e nce , s urge ry is th e onl y s trate gy for pote ntial tre atm e nt. 2, [6] [7] [8] H ow e ve r for s ucce s s ful s urgical atte m pt, one s h oul d be fam il iar w ith s ite and e xte nt of dis e as e . 9 Th e conve ntional im aging te ch niq ue s s om e tim e s s h ow ne gative re s ul ts or h ave s om e l im it at ions to be appl ie d. 10 Th e re f ore nucl e ar m e dicine te ch niq ue s are s ough t to im age , de te ct or vis ual iz e M TC. Th e various functional im aging tool s com m onl y us e d for th is purpos e are : iodinate d ( 123 I) or ( 131 I) m e taiodobe nz yl guanidine (MIBG), Th al l ium ch l oride , ( 201 Tl ), pe ntaval e nt 9 9 m Tc dim e rcaptos uccinic acid ( 9 9 m Tc(V )-DM SA), 111 In and 9 9 m Tc l abe l e d octre otide , 18 F-FDG PET, m onocl onal anti-CEA l abe l e d antibodie s , and oth e r PET trace rs , s uch as 18 F-DO PA and 68 Ga-DOTATO C or 68 Ga-DOTATATE, h ave s h ow n e ncouraging re s ul ts . [11] [12] [13] Th e s e l e ction of radioph arm ace utical s de pe nds upon th e avail abil ity, financial im pl ications and ul tim ate l y th e com fort of th e tre ating cl inician. 14 O ut of th e m 9 9 m Tc l abe l e d octre otide ( 9 9 m Tc-EDDA/H YNIC-Tyr 3 -Octre otide s cintigraph y is now cons ide re d as th e m os t appropriate m e th od for th e diagnos is , s taging and as s e s s m e nt of tre at m e nt re s pons e in MTC e s pe cial l y inl e s ions th at e xpre s s w ith s om atos tatin re ce ptors . 15 It h as m any advantage s incl uding fas t cl e arance , e as y l abe l ing, rapid tis s ue pe ne trationand l e s s e r tim e to s can th e patie nt . In our cl inical s e t up w h e re pat ie nt s fl ow is l im ite d and cl inical indications are fe w , th e trace r is not al w ays re adil y avail abl e at m any ins tit ute s and its price al s o m ak e s it unaffordabl e by m any pat ie nts w h ich m igh t de l ay th e im aging proce dure s . Al te rnative l y 9 9 m Tc(V)-DM SA h as a crucial rol e in th e pre ope rative e val uation, as s e s s m e nt of re s idual dis e as e or re curre nce of M TCand oth e r re l ate d s oft tis s ue tum ors . 14,16-18 But now th e us e of th is age nt is going to be abandone d in m os t countrie s due to th e introduction of ne w e r al te rnative s l ik e 68 Ga-DOTATOC or 68 Ga-DOTATATE. 19 H ow e ve r s e ve ral auth ors s til l be l ie ve th at 9 9 m Tc(V )-DM SA is th e m os t cos t e ff e ctive and tim e e fficie nt tool f or im aging M TC. 20 Pre vious l y publ is h e d w ork from our ins titut e al s o s ugge s t 9 9 m Tc(V )-DM SA, a good tum or s e e k ing age nt for vis ual iz ation of M TC and its invol ve d l ym ph node s in th e m e diastinum . 9 ,21 As 9 9 m Tc(V )-DMSA can be e as il y f orm ul ate d from th e re nal DM SA k it and h as com parabl e re s ul ts w ith 9 9 m Tc-EDDA/H YNIC-Tyr 3 -O ctre otide (Te k trotyd), w e s ucce s s ful l y im age d a patie nt s of MTC w it h l ocal l y form ul ate d 9 9 m Tc(V)-DM SA and th e n m ade its comparis on w ith th e re s ul ts of 9 9 m Tc-EDDA/H YNIC-Tyr 3 -Octre ot ide (Te k trot yd) s cintigraph y f orl e s ion de te ction s e ns itivitie s .
ph arm ace utical w as l ocal l y pre pare d us ing re nal DM SA k it. 9 Th e com m e rcial DM SA k it s uppl ie d by Is otope Production Divis ion (IPD), PINSTECH , Is l amabad, Pak is tan th at contains 1m g DMSA, 0.35 m g of SnCl 2. 2H 2O , 0.35 m g of As corbic acid and 20 m g of m annitol w as tak e n and w e re m ixe d w ith 1m l of 0.167M s odium bicarbonate s ol ution to m ak e th e m e dium al k al ine . Th e pH of th e re action m ixture w as (8.4-8.5) de te rm ine d by pH indicator s trips . Th e n 20m Ci (740M Bq ) of fre s h l y e l ute d Sodium Pe rte cne tate (Na 9 9 m TcO4) from M o 9 9 /Tc 9 9 m Ge ne rator w as adde d to th e vial . Th e vial w as incubate d for 15 m inute s at room te m pe rat ure f or re action to com pl e te . Qual ity control te s ts w e re carrie d out by th in-l aye r ch rom atograph y (TLC) andth e radioch e m ical purity (RCP) w as found to be 9 5.6 ± 0.5% . Th e w h ol e proce s s w as carrie d out unde r as e ptic condition. Th e radioph arm ace utical w as th e n inje cte d into th e m e dian cubit al ve in of th e patie nt th rough an indw e l l ing IV cannul a. Earl y 2-3 h rs (Fig. 1a & 1b) and de l aye d 24 h rs (Fig. 1c) ante rior s pot im age s of th e ce rvicoth oracic re gion and abdom e n w e re acq uire d us ing Sie m e ns O rbitor Gam m a cam e ra w ith l ow e ne rgy al l purpos e (LEAP) col l im ator and e ne rgy w indow of 15% ce nte re d at 141Ke V ph otope ak .
Cas e Re port
A 35 ye ars ol d m al e w as diagnos e d one ye ar ago as a cas e of M TC afte r e xcis ion biops y from ne ck s w e ll ing, w as re fe rre d to nucl e ar m e dicine de partm e nt from oncol ogy s e ction f or s om at os tat in re ce pt or s cintigraph y. At th e tim e of pre s e nt ation, h is s e rum cal citonin l e ve l w as 6324pg/m l (norm al range is <8.4). H ow e ve r due to nonavail abil ity of th is radioph arm ace utical , it w as de cide d to pe rform 9 9 m Tc(V)-DMSA s can f or th is patie nt. O w ing to our pre vious e xpe rie nce , th e radio- (Fig. 2a) and 4h rs (Fig. 2b) pos t inje ction, w h ol e body im aging w as pe rform e d on th e s am e ins titutional protocol s . Al l th e im age s w e re com pare d and inte rpre te d by th e nucl e ar ph ys ician in vie w of th e cl inical pre s e ntation of th e patie nt . Th e im age s w e re ve ry s h arp w ith e xce ll e nt re s ol ution and th e l e s ion de te ction pote ntial s w e re com m on in both th e cas e s . M ark e d uptak e of both th e radiotrace r w as s e e n in f our foci of th e ne ck th oracic re gion and s h ow e d good radiotrace rs avidity by th e l e s ions . Th e num be r of l e s ions de te cte d by th e 9 9 m Tc(V)-DM SA on th e initial s can in th e ne ck and th orax re gion w e re found to be th e s am e as de te cte d l at e r by 9 9 m Tc-EDDA/H YNIC-Tyr 3 -Octre otide s cintigraph y. No additional f ocus w as de te cte d by th e O ctre os can.Th e 24 h rs pos t inje ctions im age s w e re additional l y acq uire d to s e e th e re dis tribution of th e trace rs ove r a l ong pe riod of tim e .
Dis cus s ion
M TC is a rare ne uroe ndocrine tum or and octre otide s can is cons ide re d as a s pe cific im aging age nt for de te ction of prim ary and m e tas tatic M TC w ith h igh e r s e ns itivity. 22 Som atos tatin re ce ptor s cintigraph y is us e d to de te ct th e prim ary tum or focus for s taging, de cis ion of th e rapy prot ocol , and e val uation of th e rapy re s pons e in ne uroe ndocrine tum ors and ot h e r re l at e d cance rs . 23 It h as prove d to be be tte r th an oth e r diagnos tic tool s in th e de te ction of ce rvical and m e dias tinal l ym ph node m e tas tas e s in M TC or oth e r s om at os tat in re ce pt or-pos it ive tum ors . 24 Se ve ral s tudy s upport th at th e s e ns itivity and s pe cificity of O ctre os can is h igh e r th an th at of 9 9 m Tc (V)-DM SA in th e w ork up of M TC. 25 H ow e ve r l im it at ions are as s ociate d w ith th is radiotrace r l ik e avail abil ity and h igh price s . In m os t de ve l oping and unde r de ve l ope d countrie s , it is im porte d from oth e r de ve l ope d countrie s and patie nts h ave to w ait f or a prol ong duration. Patie nt's aff ordabil it y is anoth e r m ajor h urdl e in its routine us e . In s uch conditions 9 9 m Tc DM SA (V) s canning is an affordabl e and a re as onabl y s e ns itive im aging age nt for l ocal iz ation of re curre nt or m e tas tat ic dis e as e . 9 9 m TcDM SA(V) is a non s pe cific m ul tifunctional im aging age nt th at com m onl y accum ul ate s in MTC. 26 Its rol e in th e e val uation of M TC h as al re ady be e n compare d w it h ot h e r functional im aging tool s l ik e 131 IMIBG, 9 9 m Tc te trofos m in and 201 Tl s cintigraph ye tc. 21,27 9 9 m TcDMSA (V ) pl ays a crucial rol e in th e as s e s s m e nt of re s idual tum or or m e tas tatic dis e as e in patie nts w ith m e dul l ary th yroid cance re s pe cial l y w ith h igh pos tope rative cal citonin l e ve l s . 14 Th e e as e of preparation of 9 9 m TcDMSA(V) and good im aging ch aracte ris tics of th e radioph arm ace utical m ak e it an al te rnative im aging tool in patie nts h aving prove n M CT. 20 M TC is an uncom m on NET and patie nts are ne ith e r re adil y avail abl e nor al w ays com pl iant for th e te dious proce dure s of re s e arch . 21 H e nce furth e r s tudie s are ne e de d to be tte r de fine th e rol e of 9 9 m Tc DM SA(V) in MTC patie nts . Our e xpe rie nce of avid and pe rs is te nt 9 9 m TcDM SA(V) uptak e in al l th e tum or de pos its in th e th oracic re gion h ave e ncourage d us to e xpl ore its pote ntial s w h e re EDDA/H YNIC-Tyr 3 -O ctre otide and 68 G a-D O TATO C or 68 G a-DO TATATE is not avail abl e . More ove r, 9 9 m Tc DMSA (V ) s h ow l ow upt ak e in th e l ive r and s pl e e n as com pare d to O ctre otide s can, h e nce th e uptak e in th e s e re gion w il l be cl e arl y appre ciate d w h e re it w il l be ove rs h adow w ith octre otide . Th e prol ong re s ide nce of th e of 9 9 m Tc DMSA (V ) can al s o be util iz e d f or an al te rnate th e rape utic option w h e n tagge d w it h ß e m itting radionucl ide s l ik e 188 Re , 186 Re and oth e rs .
Concl us ion
Local l y form ul ate d 9 9 m TcDM SA (V) s cintigraph y is an e as y, e conom ical and prom is ing im aging m odal ity in MTC patie nts w it h h igh l e ve l s of cal citonin. In com paris on w ith 9 9 m Tc-EDDA/H YNIC-Tyr 3 -octre otide s cint igraph y, its avail abil ity and appl ication is e as ie r. It can be us e d as an al te rnative im aging m e th od w h e n 9 9 m Tc-E D DA/H Y NIC-Tyr 3 -octre otide and 6 8 G a-DOTATOC or 68 Ga-DOTATATE is not avail abl e .
